The advanced-packaging gold rush feels like a 2023-onward phenomenon, but the IP that underwrites it has a longer paper trail — and reading the old grants against the new ones is how you see who positioned early. The clearest example in the record is an interposer patent that predates the hype by half a decade.
Micron Technology, Inc.'s US9748184B2, "Wafer level package with TSV-less interposer" (issued 2017-08-29; CPC H01L 23/585, 23/498, 25/0655), claimed something prescient: a 2.5D-style package that routes between dies without through-silicon vias (TSVs). TSVs — vertical holes etched and filled through a silicon interposer — are expensive and yield-limiting, and a credible TSV-less route was a real cost lever. In 2017, that was a quiet structural patent. By 2026, with interposer and fan-out capacity the gating constraint of the AI buildout, the same idea is squarely on the commercial critical path.
Set the 2017 grant against the current frontier. Taiwan Semiconductor Manufacturing Company, Ltd.'s US12648153B2, "Semiconductor device packages and methods of formation" (issued 2026-06-02), sits in the same lineage of substrate-free / fan-out integration (H10B 80/00, H10W packaging classes). The conceptual through-line — get the routing density of an interposer without paying the full TSV-interposer cost — connects the 2017 claim to the 2026 product. The market caught up to the idea; the question for an IP team is who holds the claims along that path.
This is the "from claim to market" pattern in its purest form. A structural claim filed years ahead of demand is dormant capital. When the market arrives, it converts into one of three things: a licensing position, a cross-license bargaining chip, or — if the holder commercializes — a freedom-to-operate advantage over latecomers. The careful read here is that I am describing the technical and temporal relationship between these grants, not asserting that any specific product infringes any specific claim; that determination requires claim-by-claim mapping against a real package.
The commercialization caveat is load-bearing. A 2017 patent's term is finite — US utility patents run twenty years from filing — so an early position is also a depleting one. Part of reading the packaging race is noticing which foundational interposer and fan-out claims are aging out of force versus which 2024–2026 grants are extending the wall forward. Micron's 2017 grant is leverage now; it will not be leverage indefinitely, which is itself a strategic fact for anyone negotiating around it.
The lesson for IP risk and commercialization: when a technology suddenly becomes the bottleneck, the decisive patents were usually filed before anyone called it a bottleneck. The TSV-less interposer line — from Micron's 2017 grant to TSMC's 2026 packages — is a case study in early positioning paying off, and a reminder to read a thicket's foundation, not just its frontier.